Research Areas

Emergent Research: COVID-19 Therapeutics and Prevention

The company is engaged in ongoing human clinical trials for the use of Hexagen® in the treatment and prevention of COVID-19.


Onychomycosis is a highly prevalent fungal infection affecting 35M people in the US.

Atopic Dermatitis

Atopic dermatitis is a common, often persistent skin disease that affects a large percentage of the world’s population.

Herpes Zoster Ophthalmicus

Herpes Zoster Ophthalmicus is caused by varicella zoster virus (Shingles) reactivation within the ophthalmic division of the trigeminal nerve.

Chronic Wounds

A chronic wound is a wound that does not heal in an orderly set of stages in a predictable amount of time. Wounds that do not heal within 10-12 weeks are often considered chronic.


Our work—aimed at discovering cures—is a constant evolution and a challenge to the status quo. If modern medicine is the book, we will be the next breakthrough chapter.

– Bradley Burnam, CEO

Turn Therapeutics Reaches Licensing and Distribution Agreement with MIMEDX